Internal Medicine (Tokyo, 1992) 2009-01-01

Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA).

Yukiko Tada, Naomi Ikuta, Kiyoshi Negoro

Index: Intern. Med. 48(24) , 2141-4, (2009)

Full Text: HTML

Abstract

Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA) is a rare primary headache syndrome. The diagnostic criteria include attacks of unilateral orbital, supraorbital or temporal stabbing pain accompanied by one of the following: conjunctival injection and/or tearing, nasal congestion and/or rhinorrhea, and eyelid edema. The duration of pain is 2 seconds to 10 minutes, and the frequency of attacks is described as once a day or more. The etiology and pathology of SUNA has yet to be documented. We report an 18-year-old man with SUNA. Lomerizine hydrochloride which is used as a preventive medicine for migraine, improved his headaches.


Related Compounds

Related Articles:

A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity.

2015-06-03

[Sci. Transl. Med. 7 , 290ra89, (2015)]

Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity.

2011-12-01

[Mol. Cell Biochem. 358(1-2) , 1-11, (2011)]

Goshuyuto, a traditional Japanese medicine for migraine, inhibits platelet aggregation in guinea-pig whole blood.

2008-09-01

[J. Pharmacol. Sci. 108(1) , 89-94, (2008)]

CJZ3, a lomerizine derivative, modulates P-glycoprotein function in rat brain microvessel endothelial cells.

2006-04-01

[Acta Pharmacol. Sin. 27(4) , 414-8, (2006)]

A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat.

2006-03-01

[Curr. Eye Res. 31(3) , 273-83, (2006)]

More Articles...